1. Home
  2. ONMD vs INKT Comparison

ONMD vs INKT Comparison

Compare ONMD & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • INKT
  • Stock Information
  • Founded
  • ONMD 2006
  • INKT 2017
  • Country
  • ONMD United States
  • INKT United States
  • Employees
  • ONMD N/A
  • INKT N/A
  • Industry
  • ONMD
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • ONMD
  • INKT Health Care
  • Exchange
  • ONMD Nasdaq
  • INKT Nasdaq
  • Market Cap
  • ONMD 32.5M
  • INKT 43.0M
  • IPO Year
  • ONMD N/A
  • INKT 2021
  • Fundamental
  • Price
  • ONMD $0.98
  • INKT $9.96
  • Analyst Decision
  • ONMD
  • INKT Strong Buy
  • Analyst Count
  • ONMD 0
  • INKT 2
  • Target Price
  • ONMD N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • ONMD 123.3K
  • INKT 72.5K
  • Earning Date
  • ONMD 12-17-2024
  • INKT 03-20-2025
  • Dividend Yield
  • ONMD N/A
  • INKT N/A
  • EPS Growth
  • ONMD N/A
  • INKT N/A
  • EPS
  • ONMD 0.01
  • INKT N/A
  • Revenue
  • ONMD $957,651.00
  • INKT N/A
  • Revenue This Year
  • ONMD N/A
  • INKT N/A
  • Revenue Next Year
  • ONMD N/A
  • INKT N/A
  • P/E Ratio
  • ONMD $116.09
  • INKT N/A
  • Revenue Growth
  • ONMD 1.36
  • INKT N/A
  • 52 Week Low
  • ONMD $0.46
  • INKT $4.56
  • 52 Week High
  • ONMD $3.37
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 37.83
  • INKT 59.75
  • Support Level
  • ONMD $0.92
  • INKT $7.32
  • Resistance Level
  • ONMD $1.06
  • INKT $13.79
  • Average True Range (ATR)
  • ONMD 0.10
  • INKT 2.07
  • MACD
  • ONMD -0.03
  • INKT 0.28
  • Stochastic Oscillator
  • ONMD 2.40
  • INKT 71.94

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: